93 related articles for article (PubMed ID: 9345375)
21. Experimental allergic encephalomyelitis as a guide to the understanding and treatment of multiple sclerosis.
Whitaker JN; Mitchell GW
Ann Neurol; 1993 Nov; 34(5):636-7. PubMed ID: 8239557
[No Abstract] [Full Text] [Related]
22. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
[TBL] [Abstract][Full Text] [Related]
23. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.
Gross DJ; Weiss L; Reibstein I; Hedlund G; Dahlén E; Rapoport MJ; Slavin S
Int Immunopharmacol; 2001 Jun; 1(6):1131-9. PubMed ID: 11407307
[TBL] [Abstract][Full Text] [Related]
24. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
Chatzimanolis N; Kraus J; Bauer R; Engelhardt B; Bregenzer T; Kuehne BS; Tofighi J; Laske C; Stolz E; Blaes F; Voigt K; Traupe H; Kaps M; Oschmann P
Acta Neurol Scand; 2004 Dec; 110(6):377-85. PubMed ID: 15527450
[TBL] [Abstract][Full Text] [Related]
25. Multiformic modulation of endotoxin effects by linomide.
Shalev M; Ko A; Gelderman MP; Fortin E; Reed G; Slavin S; Gery I
Clin Immunol; 1999 Dec; 93(3):250-5. PubMed ID: 10600336
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).
Slavin S; Weiss L; Xia W; Gross DJ
Cell Transplant; 1996; 5(6):627-30. PubMed ID: 8951220
[TBL] [Abstract][Full Text] [Related]
27. Modulation of experimental systemic lupus erythematosus with linomide.
Zandman-Goddard G; George J; Levy Y; Blank M; Slavin S; Shoenfeld Y
Lupus; 1996 Aug; 5(4):328-33. PubMed ID: 8869907
[TBL] [Abstract][Full Text] [Related]
28. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes.
Slavin S; Sidi H; Weiss L; Rosenman E; Kalland T; Gross D
Diabetes Metab Rev; 1993 Dec; 9(4):311-5. PubMed ID: 7924828
[No Abstract] [Full Text] [Related]
29. Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice.
Hartoft-Nielsen ML; Rasmussen AK; Kaas A; Bock T; Buschard K; Feldt-Rasmussen U
Autoimmunity; 2001; 33(2):79-84. PubMed ID: 11264786
[TBL] [Abstract][Full Text] [Related]
30. Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation.
Hokland M; Jørgensen H; Holm MS; Simonsson B; Nilsson B; Bengtsson M; Hokland P
Eur J Haematol; 1999 Oct; 63(4):251-8. PubMed ID: 10530414
[TBL] [Abstract][Full Text] [Related]
31. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
Rapoport MJ; Weiss L; Mor A; Bistritzer T; Ramot Y; Slavin S
J Immunol; 1996 Nov; 157(10):4721-5. PubMed ID: 8906854
[TBL] [Abstract][Full Text] [Related]
32. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
Montalban X; Sastre-Garriga J; Tintoré M; Brieva L; Aymerich FX; Río J; Porcel J; Borràs C; Nos C; Rovira A
Mult Scler; 2009 Oct; 15(10):1195-205. PubMed ID: 19797261
[TBL] [Abstract][Full Text] [Related]
33. Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway.
Arbel I; Chezen E; Abramsky O; Karpati T; Ovadia H; Mizrachi-Koll R; Karussis D
Clin Immunol; 1999 Jan; 90(1):108-14. PubMed ID: 9884358
[TBL] [Abstract][Full Text] [Related]
34. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Abdul-Hai A; Hershkoviz R; Weiss L; Lider O; Slavin S
Int Immunopharmacol; 2005 Feb; 5(2):231-9. PubMed ID: 15652754
[TBL] [Abstract][Full Text] [Related]
35. Linomide improves the effect of interstitial laser thermotherapy in a rat liver tumour model.
Ivarsson K; Sturesson C; Stenram U; Tranberg KG
Anticancer Res; 2003; 23(2B):1257-63. PubMed ID: 12820380
[TBL] [Abstract][Full Text] [Related]
36. Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells.
Xiao BG; Bail XF; Zhang GX; Hedlund G; Link H
Neurosci Lett; 1998 Jun; 249(1):17-20. PubMed ID: 9672378
[TBL] [Abstract][Full Text] [Related]
37. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
Vukanovic J; Isaacs JT
Cancer Res; 1995 Apr; 55(7):1499-504. PubMed ID: 7533663
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
[TBL] [Abstract][Full Text] [Related]
39. Linomide and interleukin-2 in patients with advanced renal cell carcinoma.
Deckert M; Franzke A; Buer J; Probst M; Duensing S; Lopez-Haenninen E; Kirchner H; Poliwoda H; Atzpodien J
Cancer Biother Radiopharm; 1996 Oct; 11(5):319-24. PubMed ID: 10851512
[TBL] [Abstract][Full Text] [Related]
40. Lessons from linomide: a failed trial, but not a failure.
Schwid SR; Trotter JL
Neurology; 2000 May; 54(9):1716-7. PubMed ID: 10802772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]